# ğŸ§ªğŸ“ˆ Survival Analysis of Chlorhexidine Trial Outcomes Using Python  

<p align="center">

  <!-- FULL BADGE COLLECTION -->
  <img src="https://img.shields.io/badge/Field-Clinical%20Data%20Science-blue?style=for-the-badge">
  <img src="https://img.shields.io/badge/Domain-Survival%20Analysis-orange?style=for-the-badge">
  <img src="https://img.shields.io/badge/Method-Kaplan--Meier%20%7C%20Cox%20PH-green?style=for-the-badge">
  <img src="https://img.shields.io/badge/Data-Clinical%20Trial%20(VAP%20Study)-purple?style=for-the-badge">
  <img src="https://img.shields.io/badge/Source-Randomized%20Controlled%20Trial-red?style=for-the-badge">
  <img src="https://img.shields.io/badge/Python-3.10+-yellow?style=for-the-badge&logo=python">
  <img src="https://img.shields.io/badge/Libraries-lifelines%2C%20pandas%2C%20matplotlib-brightgreen?style=for-the-badge">
  <img src="https://img.shields.io/badge/Status-Completed-success?style=for-the-badge">
  <img src="https://img.shields.io/badge/License-MIT-green?style=for-the-badge">


</p>

<hr>

This project is based on a real clinical trial case study titled:  
**â€œEffectiveness of Oral Hygiene with Chlorhexidine Mouthwash with 0.12% and 0.2% Concentration on Incidence of VAPâ€**  
Published in *Annals of International Medical and Dental Research (2021)*.  

The complete article is included in the repository at:  
ğŸ“„ `/document/Publication.pdf`  

This repository reproduces and interprets **time-to-VAP (Ventilator-Associated Pneumonia)** outcomes using classical Survival Analysis methods in Python.  
All results, tables, and plots are generated using the Python analysis script and Jupyter workflow.

---

# 1ï¸âƒ£ Project Title  
**Survival Analysis of Chlorhexidine Trial Outcomes Using Python**

---

# 2ï¸âƒ£ Project Summary âœï¸  
This project analyzes patient-level data from a randomized controlled trial comparing **0.12% vs 0.20% chlorhexidine mouthwash** for preventing Ventilator-Associated Pneumonia (VAP) in intubated ICU patients.

**Outcome:**  
- Time (days) until VAP (event = 1)  
- Censoring for discharge, LAMA, or death (event = 0)

**Why survival analysis?**  
Because follow-up duration is variable, and many patients are censored â€” requiring **Kaplanâ€“Meier**, **Log-Rank**, and **Cox Proportional Hazards** models.

**Learning outcomes:**  
Kaplanâ€“Meier estimation, Log-Rank test, Cox modelling, Schoenfeld tests, adjusted survival curves, hazard interpretation.

---

# 3ï¸âƒ£ Dataset Description ğŸ“š  

**Source:** Hospital-based randomized controlled trial (n = 140).  
**Working data:** Cleaned dataset based on `/data/Chlorhexidine Trials Data Cleaned.xlsx`.

### ğŸ“˜ **Core Variables**

| Column           | Description                            | Type        |
|------------------|----------------------------------------|-------------|
| Age              | Age in years                           | Continuous  |
| Gender           | Male / Female                          | Categorical |
| TrialArm_num     | 1 = 0.12%, 2 = 0.20%                   | Categorical |
| APACHEII         | Severity score                         | Continuous  |
| TLC_D1           | Day-1 leukocyte count                  | Continuous  |
| time             | Time to VAP / censoring                | Continuous  |
| event            | 1 = VAP, 0 = No VAP                    | Binary      |

---

# 4ï¸âƒ£ Problem Statement â“  
This project answers key clinical questions:

- Does **chlorhexidine 0.20%** reduce the hazard of VAP compared to 0.12%?
- Is VAP-free survival different between treatment groups?
- Do baseline predictors (Age, APACHE II, TLC D1, Gender) influence time to VAP?
- Do survival curves differ significantly via Log-Rank test?
- What do hazard ratios from the Cox model imply clinically?

---

# 5ï¸âƒ£ Objectives ğŸ¯  

- Clean and preprocess clinical trial dataset  
- Perform EDA and baseline descriptive statistics  
- Estimate survival curves (overall and by treatment arm)  
- Compare groups with Log-Rank test  
- Fit Cox PH model and extract hazard ratios  
- Check PH assumption with Schoenfeld residuals  
- Generate adjusted survival curves  
- Interpret survival and hazard outputs clinically  

---

# 6ï¸âƒ£ Methodology ğŸ› ï¸  

## 6.1 Data Preparation  
- Renamed columns (APACHE II â†’ APACHEII, TLC Day 1 â†’ TLC_D1)  
- Encoded categorical variables (gender, trial arm)  
- Ensured numeric time/event columns  
- Imputed missing APACHEII and TLC_D1 using median values  

## 6.2 Exploratory Data Analysis ğŸ”  
- Summary statistics  
- Histograms for Age, APACHEII, TLC  
- Event distribution by arm  
- Life tables  
- Initial KM survival visualization  

## 6.3 Survival Modelling  
- Kaplanâ€“Meier overall  
- KM by treatment arm  
- Log-Rank test  
- Cox Proportional Hazards model  
- PH assumption checks  
- Adjusted survival curves for Age, APACHEII, Treatment Arm  

---

# 7ï¸âƒ£ Python Implementation Structure ğŸ’»  

```
.
â”œâ”€â”€ data/
â”‚ â”œâ”€â”€ Chlorhexidine Trials Data Cleaned.xlsx
â”‚ â”œâ”€â”€ Data form Chlorhexidine Trial (Raw).xlsx
â”‚
â”œâ”€â”€ document/
â”‚ â”œâ”€â”€ Publication.pdf
â”‚
â”œâ”€â”€ results/
â”‚ â”œâ”€â”€ km_overall.png
â”‚ â”œâ”€â”€ km_by_arm.png
â”‚ â”œâ”€â”€ km_summary.png
â”‚ â”œâ”€â”€ cox_summary.png
â”‚ â”œâ”€â”€ cox_forest.png
â”‚ â”œâ”€â”€ ph_age.png
â”‚ â”œâ”€â”€ ph_gender.png
â”‚ â”œâ”€â”€ ph_apache.png
â”‚ â”œâ”€â”€ ph_treatment.png
â”‚ â”œâ”€â”€ ph_tlcd1.png
â”‚ â”œâ”€â”€ adj_curve_age.png
â”‚ â”œâ”€â”€ adj_curve_apache.png
â”‚ â”œâ”€â”€ adj_curve_treatment.png
â”‚
â”œâ”€â”€ survival_analysis_of_chlorhexidine_trial_patients.py
â”œâ”€â”€ requirements.txt
â””â”€â”€ README.md
```

---


---

# 8ï¸âƒ£ Key Visualizations, Results & Interpretation ğŸ“Š  

### **1. Kaplanâ€“Meier (Overall)**
- Survival remains >0.90 for most of the 10-day follow-up.  
- Final survival â‰ˆ **0.78**, showing most patients remained VAP-free.
### ğŸŸ¦ **Overall KM Curve**
<div align="center">
  <img src="results/km_overall.png" width="600">
</div>
  

### **2. KM by Trial Arm**
- Both arms show high VAP-free survival.  
- Arm 2 slightly higher, but curves largely overlap.  
- Log-Rank p = **0.94** â†’ No significant difference.
### ğŸŸ© **KM by Treatment Arm**
<div align="center">
  <img src="results/km_by_arm.png" width="600">
</div>

### **3. Cox PH Model**
- All predictors have HR â‰ˆ 1  
- TrialArm HR = **0.97** (not significant)  
- Low events (10 total) â†’ wide CI â†’ limited precision  
- Concordance â‰ˆ 0.59 (weak predictive power)
### ğŸŸ§ **Cox Model Summary**
<div align="center">
  <img src="results/cox_summary.png" width="600">
</div>

### **4. PH Assumption**
- All variables have p > 0.05  
- PH assumption **not violated**  
- Model is statistically valid
### ğŸ”µ **PH Assumption Plots**
<div align="center">
  <img src="results/ph_age.png" width="600"><br>
  <img src="results/ph_apache.png" width="600"><br>
  <img src="results/ph_treatment.png" width="600"><br>
  <img src="results/ph_gender.png" width="600"><br>
  <img src="results/ph_tlcd1.png" width="600">
</div>

### **5. Forest Plot Interpretation**
- Wide CI for predictors due to very few events  
- No strong or significant hazard effects detected  
### ğŸŸ¨ **Forest Plot (Hazard Ratios)**
<div align="center">
  <img src="results/cox_forest.png" width="600">
</div>

### **6. Nelsonâ€“Aalen (Cumulative Hazard)**
- Small, step-wise increases  
- Both arms identical in hazard accumulation  
### ğŸŸ£ **Adjusted Survival Curves**
<div align="center">
  <img src="results/adj_curve_age.png" width="600"><br>
  <img src="results/adj_curve_apache.png" width="600"><br>
  <img src="results/adj_curve_treatment.png" width="600">
</div>
---

# ğŸ”Ÿ Discussion ğŸ’¬  
Both chlorhexidine concentrations maintained **high VAP-free survival**.  
Although 0.20% had fewer raw events, survival timing was nearly identical.

Cox modelling confirmed:  
- No baseline variable showed significant hazard change  
- Both concentrations behave similarly within 10-day ICU observation

---

# 1ï¸âƒ£1ï¸âƒ£ Conclusion âœ…  

- Both concentrations show **high VAP-free survival**  
- No statistically significant difference in time-to-VAP between arms  
- Cox model shows no meaningful effect of Age, APACHE II, TLC D1, Gender, Trial Arm  
- Low event count limits precision but shapes overall conclusion  
- **Both mouthwash concentrations perform similarly** clinically  

---

# 1ï¸âƒ£2ï¸âƒ£ Future Work ğŸ”­  

- Evaluate **time-varying** covariates  
- Fit parametric models (Weibull, Exponential)  
- Train ML survival models (Random Survival Forest, DeepSurv)  
- Validate on external datasets (e.g., MIMIC-III/IV)  
- Competing risks modelling (VAP vs death)  

---

# ğŸ“š Citation  
Original Trial Paper: *Vyas et al., 2021*  
Notebook / Script: `survival_analysis_of_chlorhexidine_trial_patients.py`  
PDF: `/document/Publication.pdf`

---

# ğŸ“„ License  
This project is licensed under the **MIT License**.  
You are free to use, modify, and distribute with attribution.

---

<p align="center"><img src="https://img.shields.io/badge/Author-Dr.%20Vaishnavi%20K%20R-blue?style=for-the-badge"></p>

---

**End of README**  


# 7ï¸âƒ£ Python Implementation Structure ğŸ’»  

